Demis Hassabis recounts the founding of DeepMind, based on the core insight of combining deep learning and reinforcement learning to pursue Artificial General Intelligence (AGI).
The company's mission is a two-step plan: first, solve intelligence by building AGI, and second, use it to solve grand scientific challenges, a vision validated by the success of AlphaGo.
DeepMind's focus on 'AI for Science' has led to breakthroughs like AlphaFold, which solved the protein folding problem, and is now being applied to drug discovery via Isomorphic Labs, with the goal of drastically reducing development timelines.
Hassabis predicts AGI will be achieved around 2030 and believes AI-driven simulations will revolutionize fields like biology, weather forecasting, and even social sciences.
12 quotes
Concerns Raised
The immense technical difficulty of building AGI and accurately simulating complex biological systems.
The historical risk of being too far ahead of the technological curve, a lesson from Hassabis's first startup.
Opportunities Identified
Revolutionizing drug discovery by reducing timelines from a decade to months or weeks.
Solving grand scientific challenges in biology, material science, and energy.
Creating new fields of science through the analysis of complex AI systems and the use of AI-driven simulators.
Achieving AGI as the ultimate tool to 'solve everything else'.